95 results
SC TO-T
EX-99
DBTX
Decibel Therapeutics, Inc.
25 Aug 23
Third party tender offer statement
7:46am
, tolerability, efficacy, product profile, anticipated regulatory authority approved labeling, supply chain management considerations, the competitiveness
8-K
EX-99.1
8sy 569vpr
3 Nov 22
Regeneron Reports Third Quarter 2022 Financial and Operating Results
7:19am
8-K
EX-99.1
b49 qi84xqv6t
3 Aug 22
Regeneron Reports Second Quarter 2022 Financial and Operating Results
7:08am
8-K
EX-99.1
f3ociv3mfva90v
4 May 22
Regeneron Reports First Quarter 2022 Financial and Operating Results
7:08am
DEFA14A
gkt 74ubbjat3usgi
21 Apr 22
Additional proxy soliciting materials
4:21pm